Dublin, Jan. 04, 2017 -- Research and Markets has announced the addition of the "Endometriosis - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Endometriosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
The report profiles 38 companies including many key and niche players such as
- AbbVie Inc. (US)
- AEterna Zentaris Inc. (Canada)
- Astellas Pharma Inc. (Japan)
- AstraZeneca Plc. (UK)
- Bayer HealthCare Pharmaceuticals, Inc. (US)
- Debiopharm Group (Switzerland)
- Evotec AG (Germany)
- Kissei Pharmaceutical Co., Ltd. (Japan)
- Neurocrine Biosciences, Inc. (US)
- ObsEva SA (Switzerland)
- Pfizer, Inc. (US)
- Repros Therapeutics, Inc. (US)
- Roivant Sciences Ltd. (US)
- Takeda Pharmaceutical Company Limited (Japan)
- ValiRx Plc (UK)
Key Topics Covered:
1. Industry Overview
2. Endometriosis & Its Treatment - An Overview
3. Treatment Of Endometriosis
4. Select Clinical Trials/Product Innovations & Approvals
5. Recent Industry Activity
6. Focus On Select Global Players
7. Global Market Perspective
Total Companies Profiled: 38 (including Divisions/Subsidiaries 40)
- The United States (11)
- Canada (3)
- Japan (6)
- Europe (15)
- - France (1)
- - Germany (3)
- - The United Kingdom (2)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (4)
- Middle-East (1)
For more information about this report visit http://www.researchandmarkets.com/research/qwzt5g/endometriosis
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health


KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Bank of America's $72.5M Epstein Settlement: What You Need to Know 



